MYLAN GETS FINAL APPROVAL FOR GENERIC PLETAL

A A

The FDA has granted Mylan Laboratories final approval to market its version of Otsuka Pharmaceutical's blood circulation drug Pletal.

Mylan will market the drug in 50- and 100-mg tablets and said it will begin shipping the product immediately.